Literature DB >> 15760388

IFN-gamma decreases CTL generation by limiting IL-2 production: A feedback loop controlling effector cell production.

Luis G Hidalgo1, Joan Urmson, Philip F Halloran.   

Abstract

IFN-gamma is produced by cytotoxic T lymphocytes (CTL) but can also decrease CTL generation. We used IFN-gamma-R1-deficient (GRKO) and IFN-gamma-deficient (GKO) mice to study the effects of IFN-gamma in MLC on the generation of CTL activity and CTL number, IL-2 production and cell proliferation. CTL activity was increased in MLC when GRKO responders or GKO stimulators and responders were used, compared to wild-type (WT) MLC. The number of cells displaying the CTL phenotype (CD3+, CD8+, CD25+) was also increased, accompanied by increased IL-2 production and proliferation. Combinations of WT or GRKO CD4+ T cells with WT or GRKO CD8+ T cells as responders showed that IFN-gamma mostly affects CD4+ T cells to limit CTL generation. Intracellular staining indicated that IL-2 production was largely by CD4+ T cells. Moreover, addition of IL-2 to WT responders mimicked GKO CTL generation and activity, whereas neutralizing IL-2 decreased CTL activity in GRKO and WT responders. Thus IFN-gamma reduces CTL generation in alloimmune responses largely by limiting proliferation of IL-2 producing CD4+ T cells. This creates a feedback loop in which effectors produce IFN-gamma that limits IL-2 production which in turn limits CTL generation.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15760388     DOI: 10.1111/j.1600-6143.2005.00761.x

Source DB:  PubMed          Journal:  Am J Transplant        ISSN: 1600-6135            Impact factor:   8.086


  8 in total

1.  Anti-gamma interferon antibodies enhance the immunogenicity of recombinant adenovirus vectors.

Authors:  Shawn S Jackson; Jörn E Schmitz; Norman L Letvin
Journal:  Clin Vaccine Immunol       Date:  2011-09-07

2.  Gamma interferon controls mouse polyomavirus infection in vivo.

Authors:  Jarad J Wilson; Eugene Lin; Christopher D Pack; Elizabeth L Frost; Annette Hadley; Alyson I Swimm; Jun Wang; Ying Dong; Cynthia P Breeden; Daniel Kalman; Kenneth A Newell; Aron E Lukacher
Journal:  J Virol       Date:  2011-07-20       Impact factor: 5.103

3.  Interferon gamma modulation of disease manifestation and the local antibody response to alphavirus encephalomyelitis.

Authors:  Victoria K Baxter; Diane E Griffin
Journal:  J Gen Virol       Date:  2016-09-22       Impact factor: 3.891

4.  IFN-gamma dictates allograft fate via opposing effects on the graft and on recipient CD8 T cell responses.

Authors:  Shana M Coley; Mandy L Ford; Samantha C Hanna; Maylene E Wagener; Allan D Kirk; Christian P Larsen
Journal:  J Immunol       Date:  2009-01-01       Impact factor: 5.422

5.  The effects of tolerance on allograft damage caused by the innate immune system.

Authors:  Ruediger Hoerbelt; Christopher L Benjamin; Tsuyoshi Shoji; Stuart L Houser; Ashok Muniappan; Rebecca S Hasse; Levi G Ledgerwood; James S Allan; David H Sachs; Joren C Madsen
Journal:  Transplantation       Date:  2008-02-15       Impact factor: 4.939

6.  Gene expression profiling in acute allograft rejection: challenging the immunologic constant of rejection hypothesis.

Authors:  Tara L Spivey; Lorenzo Uccellini; Maria Libera Ascierto; Gabriele Zoppoli; Valeria De Giorgi; Lucia Gemma Delogu; Alyson M Engle; Jaime M Thomas; Ena Wang; Francesco M Marincola; Davide Bedognetti
Journal:  J Transl Med       Date:  2011-10-12       Impact factor: 5.531

7.  Reduced neointima formation after arterial injury in CD4-/- mice is mediated by CD8+CD28hi T cells.

Authors:  Paul C Dimayuga; Kuang-Yuh Chyu; Wai Man Lio; Xiaoning Zhao; Juliana Yano; Jianchang Zhou; Tomoyuki Honjo; Prediman K Shah; Bojan Cercek
Journal:  J Am Heart Assoc       Date:  2013-05-23       Impact factor: 5.501

8.  Dynamic Changes of IFN-γ-producing Cells, TGF-β and Their Preidctive Value in Early Outcomees of Renal Transplantation.

Authors:  F Mohammadi; M H Niknam; M Nafar; B Einollahi; B Nazari; M Lessanpezeshki; M A Amirzargar; G Solgi; B Nikbin; A A Amirzargar
Journal:  Int J Organ Transplant Med       Date:  2013
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.